Trial Profile
A Retrospective, Cohort study to evaluate the role of the HLA-C*06:02 polymorphism during treatment with Adalimumab in patient with moderate-to-severe plaque psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 06 Feb 2017 New trial record
- 28 Jan 2017 Results published in the Molecular Diagnosis and Therapy